Danaher Corporation (LON:0R2B)
| Market Cap | 109.77B -9.9% |
| Revenue (ttm) | 18.25B +2.9% |
| Net Income | 2.69B -7.3% |
| EPS | 3.75 -4.5% |
| Shares Out | n/a |
| PE Ratio | 40.88 |
| Forward PE | 24.58 |
| Dividend | 0.95 (0.45%) |
| Ex-Dividend Date | Dec 26, 2025 |
| Volume | 3,648 |
| Average Volume | 18,072 |
| Open | 214.95 |
| Previous Close | 209.35 |
| Day's Range | 208.10 - 214.95 |
| 52-Week Range | 171.02 - 244.50 |
| Beta | 0.96 |
| RSI | 34.52 |
| Earnings Date | Jan 28, 2026 |
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man... [Read more]
Financial Performance
In 2025, Danaher's revenue was $24.57 billion, an increase of 2.90% compared to the previous year's $23.88 billion. Earnings were $3.61 billion, a decrease of -7.31%.
Financial numbers in USD Financial StatementsNews
Top Analyst Reports for Philip Morris, Lockheed Martin & Danaher
Philip Morris rides pricing power and smoke-free growth, while Lockheed Martin and Danaher navigate industry tailwinds and operational hurdles.
Salomon & Ludwin, LLC Buys 174 Shares of Danaher Corp (DHR)
Salomon & Ludwin, LLC Buys 174 Shares of Danaher Corp (DHR)
Vanguard Russell 3000 Index Fund Buys 1,027 Shares of Danaher Corp (DHR)
Vanguard Russell 3000 Index Fund Buys 1,027 Shares of Danaher Corp (DHR)
Vanguard Mega Cap Value Index Fund Buys 13,020 Shares of Danaher Corp (DHR)
Vanguard Mega Cap Value Index Fund Buys 13,020 Shares of Danaher Corp (DHR)
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Masim...
Notable ETF Outflow Detected - XLV, ABT, PFE, DHR
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the State Street Health Care Select Sector SPDR ETF (Symbol: XLV) where we...
BofA Withdraws Rating on Masimo (MASI) Following Danaher Acquisition
BofA Withdraws Rating on Masimo (MASI) Following Danaher Acquisition
Vanguard Russell 1000 Value Index Fund Buys 2,503 Shares of Danaher Corp (DHR)
Vanguard Russell 1000 Value Index Fund Buys 2,503 Shares of Danaher Corp (DHR)
Danaher (DHR) Expands into Patient Monitoring with $9.9 Billion Acquisition of Masimo
Danaher (DHR) Expands into Patient Monitoring with $9.9 Billion Acquisition of Masimo
This Medical-Devices Stock Is Soaring. Danaher Is Buying the Company.
Danaher (DHR) Experiences Unusual Bearish Options Activity
Danaher (DHR) Experiences Unusual Bearish Options Activity
Masimo: Danaher Acquisition Saves The Company From Lackluster Performance
Danaher is tapping the M&A well yet again. But we might have had enough
Danaher shares fell on the news that it was acquiring medtech player Masimo.
Danaher (DHR) Nears Acquisition of Masimo (MASI), Stocks React
Danaher (DHR) Nears Acquisition of Masimo (MASI), Stocks React
Danaher to Acquire Masimo in $9.9 Billion All-Cash Deal
Danaher to Acquire Masimo in $9.9 Billion All-Cash Deal
Danaher Corp (DHR) Shares Down 3.5% on Feb 17
Danaher Corp (DHR) Shares Down 3.5% on Feb 17
Danaher Corporation (DHR) Announces Strategic Merger with Masimo Corporation
Danaher Corporation (DHR) Announces Strategic Merger with Masimo Corporation
Masimo Stock on Pace for Record Gain After Danaher Strikes Deal
Masimo (MASI) Surges on Acquisition Talks with Danaher
Masimo (MASI) Surges on Acquisition Talks with Danaher
Danaher to buy Masimo in $9.9 billion deal in diagnostics push
The companies said on Tuesday that Danaher will pay $180 per share to buy Masimo. The offer represents a premium of 38.3% to Masimo's last close.
Danaher (DHR) to Acquire Masimo for $9.9 Billion
Danaher (DHR) to Acquire Masimo for $9.9 Billion
Danaher (DHR) to Acquire Masimo in $9.9 Billion Deal
Danaher (DHR) to Acquire Masimo in $9.9 Billion Deal
HVIA Equity Fund Buys 1,394 Shares of Danaher Corp (DHR)
HVIA Equity Fund Buys 1,394 Shares of Danaher Corp (DHR)
BLUEPRINT ADAPTIVE GROWTH ALLOCATION FUND Buys 1,877 Shares of Danaher Corp (DHR)
BLUEPRINT ADAPTIVE GROWTH ALLOCATION FUND Buys 1,877 Shares of Danaher Corp (DHR)
Danaher Strengthens Diagnostics Capabilities With $9.9 Bln Masimo Acquisition
(RTTNews) - Danaher Corp. (DHR), a science and technology innovator, announced Tuesday that it has entered into a definitive agreement to acquire Masimo Corp. (MASI) a specialty diagnostics provider, ...